Jonathan Carroll

Senior Research Software Engineer at HI-Bio

Jonathan Carroll has extensive work experience in the field of research and programming. Jonathan has been working as a Senior Research Software Engineer at HIBio since April 2022. Prior to that, they served as an Editor at R Weekly since June 2016. Additionally, Jonathan was the owner and founder of Irregularly Scheduled Programming, where they worked as a Principal Consultant and Junior Vice President. In this role, they provided programming consultation services, performed statistical and spatial analyses, and utilized various programming languages such as R, Python, Fortran, Swift, C, C++, Javascript, PHP, SQL, LaTeX, Mathematica, Matlab, and Microsoft Office. Previously, they worked as a Data Curator at Genentech from August 2017 to April 2022, and as a Research Scientist at the South Australian Research and Development Institute (SARDI) from April 2013 to August 2017.

Jonathan Carroll completed their education at the University of Adelaide from 2002 to 2006, where they earned a Doctor of Philosophy (PhD) degree in Theoretical and Mathematical Physics. In addition, they hold various certifications, including Learn JavaScript from Go Make Things in May 2023, Importing CSV Data into Neo4j, Cypher Fundamentals, Graph Data Modeling Fundamentals, and Neo4j Fundamentals from Neo4j in 2022, Data or Specimens Only Research from the CITI Program in May 2022, breaking-the-ice-with-regular-expressions from Code School in July 2015, and Modeling Count Data from Statistics.com The Institute for Statistics Education in May 2015. Jonathan also completed several courses in R and Python data analysis and visualization from DataCamp, but specific details such as the obtained month and year are not provided.

Location

Adelaide, Australia

Links


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


HI-Bio

HI-Bio was established on the premise that treatments for immune-mediated illnesses have the potential to provide patients with better outcomes. Many IMDs are caused by immune system cells, such as mast cells, neutrophils, plasma cells, and more, which are dysfunctional. These cells are in charge of crucial processes and functions. With the useof medicines, HI-efforts Bio uses a precision medicine strategy to target, modify or deplete key cellular disease drivers.HI-Bio was established in 2021 in San Francisco, California.


Employees

11-50

Links